A Rehabilitation Program to Increase Balance and Mobility in Ataxia of Charlevoix-Saguenay
Recruiting in Palo Alto (17 mi)
CG
Overseen byCynthia Gagnon, PhD
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: Élise Duchesne
No Placebo Group
Trial Summary
What is the purpose of this trial?
This exploratory study used a pre-post test design. The supervised rehabilitation program was performed three times a week for 8 weeks (two sessions at a rehabilitation gym and one pool session). Outcome measures included Ottawa sitting scale, 30-Second Chair Stand test, Berg Balance Scale, 10-Meter Walk Test, 6-minute Walk Test, modified Activities-specific Balance Confidence Scale and SARA scale. 10 participants will complete the training program. They will be evaluated at baseline, at week 4 (miway) and after the program.
Research Team
CG
Cynthia Gagnon, PhD
Principal Investigator
Sherbrooke University
Eligibility Criteria
Inclusion Criteria
Genetically confirmed ARSACS diagnosis; walker (indoor walking abilities with or without walking aids); ability to walk 10 meters; ability to provide informed consent
Treatment Details
Interventions
- Training program (Behavioural Intervention)
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Training programExperimental Treatment1 Intervention
8-week rehabilitation program aimed at increasing trunk and lower limb motor control on balance and walking abilities, and accomplishment of activities of daily living.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Élise Duchesne
Lead Sponsor
Trials
3
Recruited
30+
Muscular Dystrophy Canada
Collaborator
Trials
4
Recruited
170+